Skip to main content

Antios Therapeutics

Atlanta, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

$75.0M raised
Nov 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Antios Therapeutics

How much funding has Antios Therapeutics raised?
Antios Therapeutics has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Who are Antios Therapeutics's investors?
Antios Therapeutics's investors include RA Capital Management, Lumira Ventures, Fonds de solidarité FTQ, Adage Capital Management, Delos Capital.
Where is Antios Therapeutics headquartered?
Antios Therapeutics is headquartered in Atlanta, United States.
What does Antios Therapeutics do?
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
What stage is Antios Therapeutics at?
Antios Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Antios Therapeutics — Funding & Investors." VCBacked, November 3, 2021, https://www.vcbacked.co/company/antios-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Antios Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/antios-therapeutics
Wikipedia (cite web)
{{cite web |title=Antios Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/antios-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .